Top Story

PharmaMar seeks European marketing authorisation for multiple myeloma treatment in combination with dexamethasone

Application follows positive data obtained from the randomised, Phase III ADMYRE clinical trial.

Read more

Application reported to have been pulled because of late stage questions raised by regulatory author...

Read more

Historic agreement follows worldwide campaign led by Professor Dame Sally Davies and Jeremy Hunt....

Read more

Six-week consultation will allow interested parties to make their voices heard....

Read more

The privately-held biopharmaceutical company was acquired for an up-front payment of $50 million....

Read more

The companies will contribute novel drug targets and high-quality technology platforms to develop in...

Read more

If approved, olaratumab will be marketed under the trade name LARTRUVO™....

Read more

Findings presented at the 52nd European Association for the Study of Diabetes (EASD) Annual Meeting...

Read more

New report report from ABPI shows increase in collaborations and partnerships....

Read more

Scottish Medicines Consortium's SMC’s positive recommendation follows UK Marketing Authorisation in...

Read more

Data presented at the 12th European Congress on Epileptology (ECE)....

Read more